NM_004628.5:c.*684G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004628.5(XPC):​c.*684G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.886 in 686,448 control chromosomes in the GnomAD database, including 270,012 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.88 ( 59278 hom., cov: 33)
Exomes 𝑓: 0.89 ( 210734 hom. )

Consequence

XPC
NM_004628.5 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0480

Publications

14 publications found
Variant links:
Genes affected
XPC (HGNC:12816): (XPC complex subunit, DNA damage recognition and repair factor) The protein encoded by this gene is a key component of the XPC complex, which plays an important role in the early steps of global genome nucleotide excision repair (NER). The encoded protein is important for damage sensing and DNA binding, and shows a preference for single-stranded DNA. Mutations in this gene or some other NER components can result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017]
XPC-AS1 (HGNC:55014): (XPC antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 3-14145257-C-G is Benign according to our data. Variant chr3-14145257-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 343550.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XPCNM_004628.5 linkc.*684G>C 3_prime_UTR_variant Exon 16 of 16 ENST00000285021.12 NP_004619.3 Q01831-1X5DRB1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XPCENST00000285021.12 linkc.*684G>C 3_prime_UTR_variant Exon 16 of 16 1 NM_004628.5 ENSP00000285021.8 Q01831-1
ENSG00000268279ENST00000608606.1 linkn.236-65C>G intron_variant Intron 3 of 4 5 ENSP00000476275.1 V9GY05

Frequencies

GnomAD3 genomes
AF:
0.882
AC:
134115
AN:
152134
Hom.:
59223
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.872
Gnomad AMI
AF:
0.921
Gnomad AMR
AF:
0.924
Gnomad ASJ
AF:
0.883
Gnomad EAS
AF:
0.997
Gnomad SAS
AF:
0.928
Gnomad FIN
AF:
0.909
Gnomad MID
AF:
0.873
Gnomad NFE
AF:
0.861
Gnomad OTH
AF:
0.888
GnomAD2 exomes
AF:
0.904
AC:
109766
AN:
121382
AF XY:
0.902
show subpopulations
Gnomad AFR exome
AF:
0.876
Gnomad AMR exome
AF:
0.940
Gnomad ASJ exome
AF:
0.877
Gnomad EAS exome
AF:
0.999
Gnomad FIN exome
AF:
0.910
Gnomad NFE exome
AF:
0.866
Gnomad OTH exome
AF:
0.890
GnomAD4 exome
AF:
0.887
AC:
473977
AN:
534196
Hom.:
210734
Cov.:
0
AF XY:
0.888
AC XY:
256281
AN XY:
288562
show subpopulations
African (AFR)
AF:
0.871
AC:
13378
AN:
15368
American (AMR)
AF:
0.936
AC:
31575
AN:
33744
Ashkenazi Jewish (ASJ)
AF:
0.879
AC:
16818
AN:
19128
East Asian (EAS)
AF:
0.991
AC:
31700
AN:
32000
South Asian (SAS)
AF:
0.923
AC:
55583
AN:
60238
European-Finnish (FIN)
AF:
0.907
AC:
29591
AN:
32626
Middle Eastern (MID)
AF:
0.869
AC:
2062
AN:
2374
European-Non Finnish (NFE)
AF:
0.864
AC:
266782
AN:
308826
Other (OTH)
AF:
0.886
AC:
26488
AN:
29892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2777
5555
8332
11110
13887
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1020
2040
3060
4080
5100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.882
AC:
134230
AN:
152252
Hom.:
59278
Cov.:
33
AF XY:
0.886
AC XY:
65973
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.872
AC:
36209
AN:
41540
American (AMR)
AF:
0.924
AC:
14124
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.883
AC:
3067
AN:
3472
East Asian (EAS)
AF:
0.997
AC:
5173
AN:
5186
South Asian (SAS)
AF:
0.929
AC:
4489
AN:
4834
European-Finnish (FIN)
AF:
0.909
AC:
9625
AN:
10586
Middle Eastern (MID)
AF:
0.874
AC:
257
AN:
294
European-Non Finnish (NFE)
AF:
0.861
AC:
58571
AN:
68028
Other (OTH)
AF:
0.889
AC:
1877
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
809
1618
2427
3236
4045
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
902
1804
2706
3608
4510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.859
Hom.:
6169
Bravo
AF:
0.885
Asia WGS
AF:
0.958
AC:
3331
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Xeroderma pigmentosum Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arrhythmogenic right ventricular cardiomyopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Xeroderma pigmentosum, group C Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
6.0
DANN
Benign
0.56
PhyloP100
0.048
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1126547; hg19: chr3-14186757; API